相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Long-term Anti-VEGF Treatment on Viability and Function of RPE Cells
Anna Brinkmann et al.
CURRENT EYE RESEARCH (2022)
VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy
Alessandro Arrigo et al.
ANNALS OF MEDICINE (2022)
KSI-301: an investigational anti-VEGF biopolymer conjugate for retinal diseases
Hudson D. Stern et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)
Neurovascular abnormalities in retinopathy of prematurity and emerging therapies
Chang Dai et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2022)
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Nancy M. Holekamp et al.
OPHTHALMOLOGY (2022)
Treatment outcomes of combination of anti-vascular endothelial growth factor injection and laser photocoagulation in Type 1 ROP and APROP
Parveen Sen et al.
INTERNATIONAL OPHTHALMOLOGY (2022)
Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion
Yi Tang et al.
FRONTIERS IN MEDICINE (2022)
A Review of Aflibercept Treatment for Macular Disease
Rodrigo Anguita et al.
OPHTHALMOLOGY AND THERAPY (2021)
Recombinant thrombomodulin domain 1 rescues pathological angiogenesis by inhibition of HIF-1α-VEGF pathway
Yi-Hsun Huang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases
Massimo Nicolo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
Phenotyping of retinal neovascularization in ischemic retinal vein occlusion using wide field OCT angiography
Josef Huemer et al.
EYE (2021)
VEGFR1 signaling in retinal angiogenesis and microinflammation
Akiyoshi Uemura et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2021)
Photocoagulation for retinal vein occlusion
Sohan Singh Hayreh
PROGRESS IN RETINAL AND EYE RESEARCH (2021)
Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy
Yohei Tomita et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Angiogenesis as a hallmark of solid tumors-clinical perspectives
Jamal Majidpoor et al.
CELLULAR ONCOLOGY (2021)
Investigating PLGA microparticle swelling behavior reveals an interplay of expansive intermolecular forces
Crystal E. Rapier et al.
SCIENTIFIC REPORTS (2021)
End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Arshad M. Khanani et al.
OPHTHALMOLOGY RETINA (2021)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel et al.
OPHTHALMOLOGY (2020)
Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration
Troels Brynskov et al.
ACTA OPHTHALMOLOGICA (2020)
Ranibizumab port delivery system (RPDS): realising long awaited dream of prolonged VEGF suppression
Ashish Sharma et al.
EYE (2020)
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions
Mark Gillies et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)
Hypoxia induces core-to-edge transition of progressive tumoral cells: A critical review on differential yet corroborative roles for HIF-1α and HIF-2α
Keywan Mortezaee
LIFE SCIENCES (2020)
Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2020)
Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration
Beata Urban et al.
JOURNAL OF OPHTHALMOLOGY (2020)
Pericyte-Endothelial Interactions in the Retinal Microvasculature
Hu Huang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Chitosan hydrogels for sustained drug delivery
S. Peers et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Retinal and Choroidal Changes after Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration
Sang Woo Kim et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema BOULEVARD Phase 2 Randomized Trial
Jayashree Sahni et al.
OPHTHALMOLOGY (2019)
Intravenous treatment of choroidal neovascularization by photo-targeted nanoparticles
Yanfei Wang et al.
NATURE COMMUNICATIONS (2019)
Highly bioactive, bevacizumab-loaded, sustained-release PLGA/PCADK microspheres for intravitreal therapy in ocular diseases
Jiaxin Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations
Remy C. Cooper et al.
JOURNAL OF CONTROLLED RELEASE (2019)
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Results from the Randomized Phase 2 Ladder Clinical Trial
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2019)
Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis
Ba' Pham et al.
BMJ OPEN (2019)
Current perspectives on established and novel therapies for pathological neovascularization in retinal disease
Matthew Campbell et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Acute and chronic optic nerve head biomechanics and intraocular pressure changes in patients receiving multiple intravitreal injections of anti-VEGF
M. Gomez-Mariscal et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats
Nobuhiro Nagai et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-Related Macular Disease
Peter J. Kertes et al.
OPHTHALMOLOGY (2019)
Long-term therapeutic effect in nonhuman primate eye from a single injection of anti-VEGF controlled release hydrogel
Yu Yu et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma
Gaurang C. Patel et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)
Intravitreal Medications for Retinal Vein Occlusion: Systematic Review and Meta-analysis
Alireza Lashay et al.
JOURNAL OF OPHTHALMIC & VISION RESEARCH (2019)
Effects of Repeated Intravitreal Aflibercept Injection on the Corneal Endothelium in Patients With Age-Related Macular Degeneration: Outcomes From the RE-VIEW Study
Jonathan H. Lass et al.
CORNEA (2018)
Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization
Hongjie Mu et al.
DRUG DELIVERY (2018)
Clinical pharmacology of intravitreal anti-VEGF drugs
Stefano Fogli et al.
EYE (2018)
The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Monika Fleckenstein et al.
OPHTHALMOLOGY (2018)
Aflibercept Treatment Leads to Vascular Abnormalization of the Choroidal Neovascularization
Adam Wylegala et al.
JOURNAL OF HEALTHCARE ENGINEERING (2018)
Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems
Twana Mohammed M. Ways et al.
POLYMERS (2018)
Freeze-dried matrices for ocular administration of bevacizumab: comparison between subconjunctival and intravitreal administration in rabbits
Susi Burgalassi et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
Effect of nanoencapsulation using poly (lactide-co-glycolide) (PLGA) on anti-angiogenic activity of bevacizumab for ocular angiogenesis therapy
Xiao-Pei Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis
Sermsiri Sangroongruangsri et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Functional Characterization of Abicipar-Pegol, an Anti-VEGF DARPin Therapeutic That Potently Inhibits Angiogenesis and Vascular Permeability
Gerard A. Rodrigues et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes
Magdalena Edington et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Retinal pigment epithelium tears: Classification, pathogenesis, predictors, and management
Mehmet Giray Ersoz et al.
SURVEY OF OPHTHALMOLOGY (2017)
Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery
Leyuan Xu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Synthesis and Application of Injectable Bioorthogonal Dendrimer Hydrogels for Local Drug Delivery
Leyuan Xu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Comparison between the short-term outcomes of bevacizumab and ziv-aflibercept in the treatment of primary diabetic macular oedema
Mohammed Ashraf et al.
ACTA OPHTHALMOLOGICA (2017)
Intravitreal Ziv-Aflibercept: Clinical Effects and Economic Impact
Sumit Randhir Singh et al.
ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY (2017)
Development of a Sustainable Release System for a Ranibizumab Biosimilar Using Poly(lactic-co-glycolic acid) Biodegradable Polymer-Based Microparticles as a Platform
Yusuke Tanetsugu et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Effects of commonly used intravitreal anti-vascular endothelial growth factor drugs on mesenchymal stem cells derived from the limbus and ciliary body
Ugur Acar et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2016)
Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye
Rohit Bisht et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Single ocular injection of a sustained-release anti-VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model
Peter Adamson et al.
JOURNAL OF CONTROLLED RELEASE (2016)
The progress in understanding and treatment of diabetic retinopathy
Alan W. Stitt et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2016)
Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin
J. R. Costa et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Hydrogels in ophthalmic applications
Susanne Kirchhof et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease
Binbin Xie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment
Reyhaneh Varshochian et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2015)
Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye
Viet Anh Nguyen Huu et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Research Advances in Tissue Engineering Materials for Sustained Release of Growth Factors
Hai-yang Zhao et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
Chiara B. M. Platania et al.
Frontiers in Pharmacology (2015)
Injectable Chemically Crosslinked Hydrogel for the Controlled Release of Bevacizumab in Vitreous: A 6-Month In Vivo Study
Yu Yu et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2015)
Scleral Thinning After Repeated Intravitreal Injections of Antivascular Endothelial Growth Factor Agents in the Same Quadrant
Martin S. Zinkernagel et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Intravitreal Aflibercept (Eylea®): A Review of Its Use in Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion
Lily P. H. Yang et al.
DRUGS & AGING (2014)
Design of cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity
Joana F. Fangueiro et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Implants for drug delivery to the posterior segment of the eye: A focus on stimuli-responsive and tunable release systems
M. Naveed Yasin et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Comparison of Binding Characteristics and In Vitro Activities of Three Inhibitors of Vascular Endothelial Growth Factor A
Jihong Yang et al.
MOLECULAR PHARMACEUTICS (2014)
Re: Grunwald et al.: Risk of Geographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2014;121:150-61)
Raafay Sophie et al.
OPHTHALMOLOGY (2014)
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
David S. Boyer et al.
OPHTHALMOLOGY (2014)
Diabetic macular edema: new concepts in patho-physiology and treatment
Xinyuan Zhang et al.
CELL AND BIOSCIENCE (2014)
Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data
Petr Kolar
JOURNAL OF OPHTHALMOLOGY (2014)
Branch Retinal Vein Occlusion Natural History of Visual Outcome
Sohan Singh Hayreh et al.
JAMA OPHTHALMOLOGY (2014)
Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes
Ulrich Schraermeyer et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Nanoparticles in Porous Microparticles Prepared by Supercritical Infusion and Pressure Quench Technology for Sustained Delivery of Bevacizumab
Sarath K. Yandrapu et al.
MOLECULAR PHARMACEUTICS (2013)
Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010
Hannah Blencowe et al.
PEDIATRIC RESEARCH (2013)
RETINAL PIGMENT EPITHELIAL ATROPHY IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Noemi Lois et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex
Imran Bhutto et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Mechanisms of Age-Related Macular Degeneration
Jayakrishna Ambati et al.
NEURON (2012)
Molecular Characteristics and Pathways of Avastin for the Treatment of Glioblastoma Multiforme
Marko Spasic et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2012)
Efficacy of Intravitreal Bevacizumab for Stage 3+Retinopathy of Prematurity.
Helen A. Mintz-Hittner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin®) in neovascular age-related macular degeneration
Philippe Bonnin et al.
ACTA OPHTHALMOLOGICA (2010)
Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration
Lazaros Konstantinidis et al.
ACTA OPHTHALMOLOGICA (2010)
Chitosan-based hydrogels for controlled, localized drug delivery
Narayan Bhattarai et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone
Louis Hoffart et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Photo-Targeted Nanoparticles
Tal Dvir et al.
NANO LETTERS (2010)
Natural History of Branch Retinal Vein Occlusion: An Evidence-Based Systematic Review
Sophie L. Rogers et al.
OPHTHALMOLOGY (2010)
Forecasting Age-Related Macular Degeneration Through the Year 2050 The Potential Impact of New Treatments
David B. Rein et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION
Majid Abrishami et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Pharmacokinetics of Bevacizumab after Topical, Subconjunctival, and Intravitreal Administration in Rabbits
Hiroyuki Nomoto et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Arto Urtti
ADVANCED DRUG DELIVERY REVIEWS (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Zone I retinopathy of prematurity - Clinical characteristics and treatment outcomes
Andres Kychenthal et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165
JH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
N Ferrara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration
PJ Rosenfeld et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2005)
Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms -: Insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1
K Suto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Review: Practical issues in intravitreal drug delivery
D Maurice
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2001)
Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: Biodegradation
XS Wu et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2001)
分享论文
